Open in web browser

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

Diabetes & RA

FDA increases warning on diabetes medication

By Christine Blank
FDA has strengthened its warning for the type 2 diabetes medicine canagliflozin (Invokana, Invokamet) related to the increased risk of bone fractures, and added new information about decreased bone mineral density. Read more

Rituxan safe for long-term use in rheumatoid arthritis

By Christine Blank
Rituxan (rituximab) has a consistent safety profile through multiple courses over 11 years of observation, according to a new long-term study published in the online edition of The Journal of Rheumatology. Study details

CONTINUING EDUCATION

MTM essentials for allergic rhinitis management
Session code: 15DT34-XVK37

This month's CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss the pathophysiology and clinical presentation of allergic rhinitis and review nonpharmacologic and pharmacologic treatments for the symptoms of allergic rhinitis.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT34-XVK37.

Copy the session code — 15DT34-XVK37 — before logging into the Online CE Center. When the page for the Online CE Center opens, paste the session code into the appropriate field, under your NABP ID.

EDITOR'S PICK

Study: HIV PrEP drug may be 100% effective

By Tracey Walker
Pre-exposure prophylaxis (PrEP) may prevent HIV infection, according to a study published in Clinical Infectious Diseases. PrEP evaluation

September 16, 2015

Related Articles

FDA warns of joint pain for DPP-4 diabetes drugs

Rheumatoid arthritis drug may benefit atopic dermatitis patients

Sponsored links

A Systematic Approach to Weight Loss and Disease Management

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click here to contact Editorial. Sales, Reprints, Classified questions? Click here to contact the Sales Team.

ModernMedicine logo
UBM  logo

UBM MEDICA